Moderna reports early success with COVID vaccine in children under 6
Biotech company Moderna has announced the first interim data from a clinical trial testing its mRNA COVID-19 vaccine in children under the age of six. The results show similar antibody responses after two doses to those seen in adults. Moderna plans to apply for US Food and Drug Administration (FDA) emergency authorization very soon.
24 Mar 04:05 · New Atlas